Duramed (DRMD) Synthetic Estrogen Product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: CASINO1 who wrote (1312)	6/11/1999 10:25:00 AM
From: vestor	Read Replies (1) of 1837

In my analysis I am choosing to be very conservative. I am trying to minimize the optimisum..... However I would not at all be surprised if the Cenestin market penetration is greater..... A lot depends on how effective the DRMD marketing and advertising firms are.... Also a factor is when the approval kicks in for Cenestin's use for long term indications as Osteoperosis, etc... Certainly there is no place for DRMD earnings/revenues to go but up... its a matter of how much and when.....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next